Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 23 hours ago

Indications

Netarsudil Dimesylate ophthalmic solution is used to bring down raised pressure inside the eye (intraocular pressure, or IOP) in people who have open-angle glaucoma or ocular hypertension.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Netarsudil is a Rho kinase inhibitor. It acts at the cellular level in the trabecular outflow pathway, where it relaxes actin-myosin. This relaxes the trabecular meshwork and the inner wall of Schlemm's canal, and it also lowers episcleral venous pressure (EVP).

Pregnancy & Breastfeeding

Pregnancy: No adequate and well-controlled studies of Netarsudil ophthalmic solution have been done in pregnant women, so any risk linked to the medicine is not known. That said, the amount of Netarsudil that reaches the rest of the body when it is put in the eye is low.

Lactation: There are no data on whether Netarsudil passes into human milk. The effects on a breastfed infant and on milk production are also not known.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Netarsudil Dimesylate is used at a dose of one drop in the affected eye(s) once a day, in the evening. Pediatric use: safety and effectiveness have not been established in patients below 18 years of age. Use in elderly patients: no overall differences in safety and effectiveness have been seen between elderly patients and other adults.